Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

given the fact that Stelara ranks as one of the most expensive prescription drugs on the market," said Tom Nusbickel, Chief Commercial Officer at Celltrion USA. STEQEYMA will be available in the U ...

The human monoclonal antibody ustekinumab blocks the biologic activity ... It is noteworthy that this drug has U.S. Food and Drug Administration approval for patients with psoriasis.

Johnson & Johnson (J&J) has announced that Stelara (ustekinumab) has been approved by the European Commission (EC) to treat moderately to severely active Crohn’s disease (CD) in paediatric patients.

The overlap of biologics during medication switches is common in routine care of patients with IBD and isn’t linked to a ...

Occasionally, drug names are short and snappy. But more often, they seem more like something from Greek or Norse mythology. While these names may seem overwhelming at first, they’re chosen with ...